Thrombogenic properties of epsilon amino caproic acid.
D000614:Aminocaproates / Q000009:adverse effects*; D000818:Animals; D004285:Dogs; D005342:Fibrinolysis / Q000187:drug effects*; D006474:Hemorrhagic Disorders / Q000188:drug therapy*; D006493:Heparin / Q000627:therapeutic use; D066298:In Vitro Techniques; D012771:Shock, Hemorrhagic / Q000188:drug therapy; D012773:Shock, Surgical / Q000188:drug therapy; D013917:Thrombin / Q000494:pharmacology; D013927:Thrombosis / Q000209:etiology*
D000614:Aminocaproates; D006493:Heparin; D013917:Thrombin